Mycophenolate mofetil as second line treatment in autoimmune hepatitis - A retrospective single center analysis.
J Transl Autoimmun
; 5: 100172, 2022.
Article
in En
| MEDLINE
| ID: mdl-36451933
AIH, autoimmune hepatitis; ALT, alanine aminotransferase; ANA, anti-nuclear-antibodies; AZA, azathioprine; Autoimmune hepatitis; Autoimmune liver disease; Azathioprine; BDN, budesonide; CI, calcineurin inhibitor; CyA, cylcosporine A; INR, international normalized ratio; IQR, interquartile range; IgG, immunoglobuline G; LKM-1, liver-kidney-microsomal antibodies; MMF, mycophenolate mofetil; Mycophenolate mofetil; PBC, primary biliary cholangitis; PDN, prednisolone; PSC, primary sclerosing cholangitis; SLA, soluble liver antigen antibodies; SMA, smooth-muscle cell antibodies; Second line treatment; TNFi, tumor necrosis factor inhibitor; UDCA, ursodeoxycholic acid; ULN, upper limit of normal
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
J Transl Autoimmun
Year:
2022
Document type:
Article
Affiliation country: